Q95460 (HMR1_HUMAN) Homo sapiens (Human)
Major histocompatibility complex class I-related gene protein UniProtKBInterProSTRINGInteractive Modelling
Available Structures
62 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of human MAIT A-F7 TCR in complex with human MR1-2`OH-Ethyl-5-OP-U |
Heteromer P61769; | 99.62 | 1×GOL; 1×OZD; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-5'OH-Pentyl-5-OP-U |
Heteromer P61769; | 99.62 | 1×OYD; | |||
| Structure of E8 TCR in complex in human MR1 bound to 5FSA |
Heteromer P61769; | 99.62 | 1×54G; 4×EDO; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1 3'D-5-OP-RU |
Heteromer P61769; | 99.62 | 4×GOL; 1×Q81; 2×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-5-OP-RU |
Heteromer P61769; | 99.62 | 1×Q87; 1×GOL; 1×CL; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-Ribityl-less |
Heteromer P61769; | 99.62 | 1×OYG; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with patient MR1-R9H-Ac-6-FP |
Heteromer P61769; | 99.24 | 1×TKG; 2×GOL; 1×CL; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-4'D-5-OP-RU |
Heteromer P61769; | 99.62 | 1×GOL; 1×Q7J; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-3`OH-Propyl-5-OP-U |
Heteromer P61769; | 99.62 | 1×GOL; 1×CL; 1×Q7S; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-5'D-5-OP-RU |
Heteromer P61769; | 99.62 | 1×2LJ; 3×GOL; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with patient MR1-R9H without ligand |
Heteromer P61769; | 99.24 | 2×ACT; 2×GOL; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-4'OH-Butyl-5-OP-U |
Heteromer P61769; | 99.62 | 1×Q7P; 1×GOL; 2×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-2'D-5-OP-RU |
Heteromer P61769; | 99.62 | 2×GOL; 1×Q84; 3×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-DB28 |
Heteromer P61769; | 99.62 | 1×GOL; 1×P1J; 1×ACT; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT TRAJ20 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; 2×GOL; 1×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-JYM72 |
Heteromer P61769; | 99.62 | 1×GOL; 1×OYV; 2×NA; | |||
| Structure of human MAIT A-F7 TCR in complex with human MR1-NV18.1 |
Heteromer P61769; | 99.62 | 1×N18; 2×GOL; 1×ACT; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT M33.64 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; | |||
| Structure of E8 TCR in complex in human MR1 K43A |
Heteromer P61769; | 99.23 | ||||
| Crystal structure of ternary complex of human MR1, ligand #4, and MAIT-TCR A-F7 |
Heteromer P61769; | 99.62 | 1×A1LXU; | |||
| Structure of human MAIT TCR in complex with human MR1-RL-6-Me-7-OH |
Heteromer P01850; P61769; Q6P4G7; | 99.62 | 1×1VY; 2×GOL; | |||
| Structure of human MR1-3-F-SA in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.61 | 1×7ZS; 1×GOL; 1×ACT; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT B-B10 TCR |
Heteromer P61769; | 99.62 | 2×CL; 6×GOL; 3×ACT; 1×30W; 1×NA; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT M33.64(Y95alphaF) TCR |
Heteromer P61769; | 99.62 | 1×GOL; 1×2LJ; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT B-G8 TCR |
Heteromer P61769; | 99.62 | 2×GOL; 1×30W; 3×NA; | |||
| Structure of human MR1-2-OH-1-NA in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.62 | 1×7WO; 2×GOL; 2×CL; 1×NA; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT TRBV6-1 TCR |
Heteromer P61769; | 99.62 | 1×30W; | |||
| Structure of human MAIT TCR in complex with human MR1-6-FP |
Heteromer P01850; P61769; | 99.62 | 1×6FP; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT M33.64 TCR |
Heteromer P61769; | 99.62 | 1×PRO; 1×30W; 7×GOL; | |||
| Structure of E8 TCR in complex in human MR1 bound to 3FSA |
Heteromer P61769; | 99.62 | 1×7ZS; | |||
| Crystal structure of TCR-MR1 ternary complex bound to 5-(2-oxoethylideneamino)-6-D-ribitylaminourac… |
Heteromer P01850; P61769; Q6P4G7; | 99.62 | 1×2L4; | |||
| Structure of E8 TCR in complex in human MR1 bound to 4FBA |
Heteromer P61769; | 99.62 | 1×4MA; 6×EDO; | |||
| Structure of human MR1-DA-6-FP in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.62 | 1×7WP; 4×GOL; 2×NA; | |||
| Structure of human MR1-HMB in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.62 | 1×PRO; 1×7WQ; 1×GOL; | |||
| Crystal structure of TCR-MR1 ternary complex and non-covalently bound 5-(2-oxopropylideneamino)-6-D… |
Heteromer P01850; P61769; Q6P4G7; | 99.59 | 2×Q87; 1×GOL; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT C-A11 TCR |
Heteromer P61769; | 99.62 | 1×30W; 1×CL; 4×GOL; 1×B3P; | |||
| Structure of E8 TCR in complex in human MR1 bound to 3FBA |
Heteromer P61769; | 99.61 | 1×OVV; 1×EDO; 1×MPO; | |||
| The structure of human MAIT TCR in complex with MR1-K43A-RL-6-Me-7OH |
Heteromer P01850; P61769; Q6P4G7; | 99.24 | 1×GOL; 1×1VY; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT B-F3-C1 TCR |
Heteromer P61769; | 99.62 | 1×30W; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT B-C10 TCR |
Heteromer P61769; | 99.62 | 1×30W; 2×GOL; | |||
| Structure of human MR1-ethylvanillin in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.62 | 1×PRO; 1×N36; 6×GOL; | |||
| Structure of human MR1-Ac-6-FP in complex with human MAIT C-C10 TCR |
Heteromer P61769; | 99.62 | 1×30W; 1×GOL; 1×NA; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT TRBV6-4 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT C-A11 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; 1×B3P; | |||
| Structure of human MR1-5OH-DCF in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.61 | 2×ACT; 1×GOL; | |||
| Crystal structure of TCR-MR1 ternary complex and covalently bound 5-(2-oxopropylideneamino)-6-D-rib… |
Heteromer P01850; P61769; Q6P4G7; | 99.61 | 2×2LJ; 1×NA; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT B-B10 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; 1×GOL; | |||
| Structure of human MR1-diclofenac in complex with human MAIT A-F7 TCR |
Heteromer P61769; | 99.62 | 2×NA; 1×ACT; 2×GOL; 1×DIF; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT C-C10 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; 1×GOL; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT B-F3-C1 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; 2×GOL; | |||
| Structure of human D462-E4 TCR in complex with human MR1-5-OP-RU |
Heteromer P61769; | 99.59 | 1×2LJ; 2×GOL; 1×BR; 1×NA; 2×CL; | |||
| Inhibitory immune receptor protein complex |
Heteromer P61769; | 99.62 | 1×30W; | |||
| Stimulatory immune receptor protein complex |
Heteromer A0A0C4DH27; A0JD37; P61769; | 99.62 | 1×2LJ; | |||
| Structure of MHC-class I related molecule MR1 |
Heteromer P61769; | 99.62 | 1×6FP; 1×CL; 1×PO4; | |||
| Structure of human MR1-5-OP-RU in complex with human MAIT TRBV20 TCR |
Heteromer P61769; | 99.61 | 1×2LJ; 1×NA; | |||
| Recognition of MHC-like molecule |
Heteromer P61769; | 99.62 | 1×2LJ; 1×NAG; | |||
| Structure of human MR1-5-OP-RU in complex with human MAV36 TCR |
Heteromer P61769; | 99.62 | 1×2LJ; | |||
| Structure of E8 TCR in complex with human MR1 bound to 6FP |
Heteromer P61769; | 99.62 | 1×JSO; | |||
| Structure of E8 TCR in complex with human MR1 bound to 5-OP-RU |
Heteromer P61769; | 99.62 | 1×2LJ; 2×EDO; | |||
| Crystal structure of human CD8aa-MR1-Ac-6-FP complex |
Heteromer P01732; P61769; | 99.62 | 1×30W; 1×PO4; 1×CL; | |||
| Model of the Ac-6-FP/hpMR1/bB2m/TAPBPR complex from integrated docking, NMR and restrained MD |
Heteromer C1ITJ8; P01888; Q9BX59; | 100 | 1×30W; | |||
| Structure of MHC-class I related molecule MR1 with bound M3Ade | monomer | 100 | 1×R8F; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8bp6.1.A | monomer | 0.85 | 98.90 | |||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8bp6.1.A | monomer | 0.81 | 97.80 | |||
| Isoform 3 | 8bp6.1.A | monomer | 0.78 | 82.97 | |||
| Isoform 4 | 8bp6.1.A | monomer | 0.87 | 91.00 | |||
| Isoform 5 | 8bp6.1.A | monomer | 0.87 | 93.26 | |||